Terms: = Uterine cancer AND TBL1XR1, C21, 79718, TBLR1, IRA1, FLJ12894, DC42
14 results:
1. lncRNA799/tbl1xr1/ZEB1 Axis Forms a Feedback Loop to Promote the Epithelial-Mesenchymal Transition of Cervical cancer Cells.
Liao L; Huang P; Zhao J; Wang Z; Chen H; Zhang C; Huang L
Crit Rev Eukaryot Gene Expr; 2024; 34(2):33-43. PubMed ID: 38073440
[TBL] [Abstract] [Full Text] [Related]
2. Multi-region sequencing depicts intratumor heterogeneity and clonal evolution in cervical cancer.
Wang C; Bai R; Liu Y; Wang K; Wang Y; Yang J; Cai H; Yang P
Med Oncol; 2023 Jan; 40(2):78. PubMed ID: 36635412
[TBL] [Abstract] [Full Text] [Related]
3. Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
Okonogi N; Usui H; Murata K; Hori M; Kurokawa T; Fujiwara T; Fujii Y; Hanawa M; Kawasaki Y; Hattori Y; Suzuki K; Tsuyuki K; Wakatsuki M; Hasegawa S; Yamada S; Hanaoka H; Shozu M; Tsuji H
BMJ Open; 2022 Mar; 12(3):e056424. PubMed ID: 35236732
[TBL] [Abstract] [Full Text] [Related]
4. 3q26 Amplifications in Cervical Squamous Carcinomas.
Voutsadakis IA
Curr Oncol; 2021 Jul; 28(4):2868-2880. PubMed ID: 34436017
[TBL] [Abstract] [Full Text] [Related]
5. C
Zhu GL; Hao Q; Xing L; Yang XQ; Xie SD; Zhao P; Li HZ
Steroids; 2021 Aug; 172():108874. PubMed ID: 34102197
[TBL] [Abstract] [Full Text] [Related]
6. Identification and characterization of tumorigenic circular RNAs in cervical cancer.
Huang H; Chen YF; Du X; Zhang C
Cell Signal; 2020 Sep; 73():109669. PubMed ID: 32423867
[TBL] [Abstract] [Full Text] [Related]
7. Activation of intracellular angiotensin AT₂ receptors induces rapid cell death in human uterine leiomyosarcoma cells.
Zhao Y; Lützen U; Fritsch J; Zuhayra M; Schütze S; Steckelings UM; Recanti C; Namsoleck P; Unger T; Culman J
Clin Sci (Lond); 2015 May; 128(9):567-78. PubMed ID: 25487516
[TBL] [Abstract] [Full Text] [Related]
8. tblr1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer.
Wang J; Ou J; Guo Y; Dai T; Li X; Liu J; Xia M; Liu L; He M
Br J Cancer; 2014 Jul; 111(1):112-24. PubMed ID: 24874481
[TBL] [Abstract] [Full Text] [Related]
9. Mortality trends and prediction of HPV-related cancers in Brazil.
de Souza DL; Curado MP; Bernal MM; Jerez-Roig J; Boffetta P
Eur J Cancer Prev; 2013 Jul; 22(4):380-7. PubMed ID: 23238584
[TBL] [Abstract] [Full Text] [Related]
10. Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature.
Klotz RK; Müller-Holzner E; Fessler S; Reimer DU; Zervomanolakis I; Seeber B; Mattle V; Wildt L
Exp Clin Endocrinol Diabetes; 2010 May; 118(5):291-7. PubMed ID: 20198556
[TBL] [Abstract] [Full Text] [Related]
11. Synthesis and structure-activity relationship study of lamellarin derivatives.
Ishibashi F; Tanabe S; Oda T; Iwao M
J Nat Prod; 2002 Apr; 65(4):500-4. PubMed ID: 11975488
[TBL] [Abstract] [Full Text] [Related]
12. Identification of novel molecular markers which correlate with HPV-induced tumor progression.
Nees M; van Wijngaarden E; Bakos E; Schneider A; Dürst M
Oncogene; 1998 May; 16(19):2447-58. PubMed ID: 9627111
[TBL] [Abstract] [Full Text] [Related]
13. Is there an altered steroid profile in patients with endometrial carcinoma?
Möllerström G; Carlström K; Lagrelius A; Einhorn N
Cancer; 1993 Jul; 72(1):173-81. PubMed ID: 8508403
[TBL] [Abstract] [Full Text] [Related]
14. The role and use of progestogens.
Whitehead MI; Hillard TC; Crook D
Obstet Gynecol; 1990 Apr; 75(4 Suppl):59S-76S; discussion 81S-83S. PubMed ID: 2179792
[TBL] [Abstract] [Full Text] [Related]
